Author:
Chassany Olivier, ,Sagnier Pierre,Marquis Patrick,Fullerton Steve,Aaronson Neil
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Drug Guides,Pharmacology (nursing)
Reference112 articles.
1. Johnson JR, Temple R. Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat Rep 1985;69:1155–1159.
2. Lohr KN, Aaronson NK, Alonso J, Bumam MA, Patrick DL, Perrin EB, Roberts JS. Evaluating quality-of-life and health status instruments: Development of scientific review criteria. Clin Ther 1996;18:979–992.
3. Scientific Advisory Committee. Instrument Review Criteria. Med Outcomes Trust Bull 1995;3:I–IV.
4. Staquet M, Berzon R, Osoba D, Machin D. Guidelines for reporting results of quality of life assessments in clinical trials. Qual Life Res 1996;5:496–500.
5. Fayers PM, Hopwood P, Harvey A, Girling DJ, Machin D, Stephens R, on Behalf of the MR. Cancer Trials Office. Quality of Life Assessment in Clinical Trials—Guidelines and a Checklist for Protocol Writers: The U. Medical Research Council Experience. Eur J Cancer 1997;33:20–28.
Cited by
321 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献